Working with TipRanks
Follow Us
Stocks
ETFs
Options
Crypto
Currency
Research Tools
Calendars
Calculators
Education
About Us
Working with TipRanks
Follow Us
Aslan Pharmaceuticals Ltd ADR (ASLN)
NASDAQ:ASLN
RESEARCH TOOLSreports
Aslan Pharmaceuticals (ASLN) Financial Statements
360 Followers
Aslan Pharmaceuticals Financial Overview
| Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | - | ||||
| Total Revenue | - | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | - | - | - | $ 0.00 | $ 0.00 |
| EBIT | - | $ -9.97M | $ -12.16M | $ -11.85M | $ -8.39M |
| EBITDA | - | $ -9.97M | $ -12.16M | $ -11.85M | $ -8.39M |
| Net Income Common Stockholders | - | $ -10.93M | $ -13.03M | $ -12.94M | $ -8.87M |
| Balance Sheet | - | ||||
| Cash, Cash Equivalents and Short-Term Investments | $ 8.59K | $ 68.95M | $ 78.12M | $ 87.40M | $ 494.73K |
| Total Assets | $ 61.19M | $ 72.61M | $ 80.61M | $ 90.88M | $ 4.35M |
| Total Debt | $ 29.87M | $ 36.64M | $ 36.47M | $ 36.54M | $ 31.06M |
| Net Debt | $ 29.86M | $ -32.31M | $ -41.65M | $ -50.86M | $ 30.56M |
| Total Liabilities | $ 52.82M | $ 50.55M | $ 47.95M | $ 45.80M | $ 94.52M |
| Stockholders Equity | $ 8.37M | $ 22.06M | $ 32.67M | $ 45.07M | $ -5.72M |
| Cash Flow | - | ||||
| Free Cash Flow | - | - | - | - | - |
| Operating Cash Flow | - | - | - | - | - |
| Investing Cash Flow | - | - | - | - | - |
| Financing Cash Flow | - | - | - | - | - |